Vaccinia virus MVA-E3L-knockout-mutants and use thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 23, 2006
Issued Date -
N/A
app pub date -
Sep 11, 2002
filing date -
Sep 11, 2001
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention relates to mutant MVA vaccinia viruses, which are used for the generation of recombinant MVA viruses, as well as host cells, which have been infected with these mutant MVA viruses. The present invention further relates to DNA-vector constructs, and a method for the generation of recombinant MVA by using the mutant MVA viruses and the DNA-vector constructs. The mutant MVA vaccinia viruses of the present invention are characterized in that the MVA ORF 050L gene or a functional part thereof has been inactivated in the viral genome.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully